PASIREOTIDE

Drug RECORDATI_RARE_DISEASES_INC.
Total Payments
$382,273
Transactions
77
Doctors
10
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $382,273 77 10

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $382,273 77 100.0%

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
PAS576 RECORDATI_RARE_DISEASES_INC. $382,273 10

Top Doctors Receiving Payments for PASIREOTIDE

Doctor Specialty Location Total Records
, M.D Endocrinology, Diabetes & Metabolism Boston, MA $82,468 6
, MD Endocrinology, Diabetes & Metabolism Stanford, CA $61,947 9
, M.D., PH.D Endocrinology, Diabetes & Metabolism Madison, WI $54,944 20
, M.D Internal Medicine San Antonio, TX $40,791 8
, MD Obesity Medicine Chapel Hill, NC $39,042 18
, M.D General Practice Rochester, MN $38,188 4
, M.D Psychiatry Aurora, CO $35,424 4
, MD Family Medicine Snellville, GA $15,983 4
, M.D Endocrinology, Diabetes & Metabolism Houston, TX $13,195 3
, MD Family Medicine Snellville, GA $290.90 1

About PASIREOTIDE

PASIREOTIDE is a drug associated with $382,273 in payments to 10 healthcare providers, recorded across 77 transactions in the CMS Open Payments database. The primary manufacturer is RECORDATI_RARE_DISEASES_INC..

Payment data is available from 2024 to 2024. In 2024, $382,273 was paid across 77 transactions to 10 doctors.

The most common payment nature for PASIREOTIDE is "Unspecified" ($382,273, 100.0% of total).

PASIREOTIDE is associated with 1 research study, including "PAS576" ($382,273).